Claude Shaul - MEDTECHNICA Director

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>ME</div>
MEDI -- Israel Stock  

ILA 1,679  30.00  1.82%

  Director
Mr. Claude Ben Shaul serves as Vice President Operations Technologies and Director at Medtechnica Ltd. since January 1 2012. He has held the role of Director at the Company since March 6 2011. He holds the same roles at Ilex Medical Ltd.
Age: 54  Director Since 2012      
972 3 925 4018  http://www.medtechnica.co.il

MEDTECHNICA Management Efficiency

MEDTECHNICA has return on total asset (ROA) of 2.62 % which means that it generated profit of $2.62 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 7.97 % meaning that it generated $7.97 on every $100 dollars invested by stockholders. MEDTECHNICA management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.
The company has accumulated 58.33 M in total debt with debt to equity ratio (D/E) of 0.32 which is about average as compared to similar companies. MEDTECHNICA has Current Ratio of 2.54 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Ori YaronPARTNER COMMUNICAT
2014
Douglas SeslerGAZIT GLOBE
2012
Avisar PazICL ISRAEL CHEM
2001
Miriam HaranICL ISRAEL CHEM
2009
Michael DorGAZIT GLOBE
1999
Barry ZeevPARTNER COMMUNICAT
2009
Ovadia EliICL ISRAEL CHEM
2011
Ran GuronINTERNET GOLD GOLD
2011
Rosenzweig YehoshuaINTERNET GOLD GOLD
2010
Or ElovitchINTERNET GOLD GOLD
2010
Naama ZeldisNOVA MEASURING INS
2006
Ytzhak EdelmanINTERNET GOLD GOLD
2008
Yitzhak EdelmanINTERNET GOLD GOLD
2011
Limor GutmanGAZIT GLOBE
2019
Elan PennMAGIC SOFTWARE ENT
2005
Tomer ZeevPARTNER COMMUNICAT
2017
Joshua ShemerCOMPUGEN
2007
JeanPierre BizzariCOMPUGEN
2018
Raanan CohenNOVA MEASURING INS
2014
Yehezkel ZeiraMAGIC SOFTWARE ENT
2005
Dafna GruberNOVA MEASURING INS
2015

Company Summary

Medtechnica Ltd. operates as a distributor and service provider of medical equipment in Israel. The company was founded in 1953 and is based in Petah Tikva, Israel. MEDTECHNICA operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.MEDTECHNICA (MEDI) is traded on Tel Aviv Stock Exchange in Israel and employs 11 people.

MEDTECHNICA Leadership Team

Reuven Levin, Director of Marketing
Lilach Mani, Vice President - Finance
Tamar Galili, Director
Saul Yemal, External Director
Morris Benisty, External Director
Moshe Benshaul, Chief Executive Officer
Andrea SittLevy, General Counsel, Secretary
Dror Dean, Vice President of Human Resources
Galia Shlonsky, Chief Financial Officer
Tal YaronEldar, Independent Director
Tali Schachter, Head of Home Care Division
Ofer Eden, Vice President - Finance
Claude Benshaul, Vice President - Operations & Technologies, Director
Meir Kadosh, Vice President of a Division
Moshe Shaul, CEO
Claude Shaul, Director
Boaz Yehazkel, Head of Hospital Division
Nir Bachman, Vice President

Stock Performance Indicators

Current Sentiment - MEDI

MEDTECHNICA Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in MEDTECHNICA. What is your trading attitude regarding investing in MEDTECHNICA? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page